Franklin Resources
NVCR icon

Franklin Resources’s NovoCure NVCR Stock Holding History

Franklin Resources’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.58M Buy
434,360
+145,064
+50% +$2.19M ﹤0.01% 1470
2026
Q1 		$3.15M Buy
289,296
+24,402
+9% +$305K ﹤0.01% 1722
2025
Q4 		$3.43M Buy
264,894
+14,582
+6% +$187K ﹤0.01% 1578
2025
Q3 		$3.23M Buy
250,312
+73,363
+41% +$980K ﹤0.01% 1611
2025
Q2 		$3.15M Buy
176,949
+3,990
+2% +$69.5K ﹤0.01% 1546
2025
Q1 		$3.08M Buy
172,959
+16,895
+11% +$384K ﹤0.01% 1539
2024
Q4 		$4.65M Sell
156,064
-24,789
-14% -$525K ﹤0.01% 1377
2024
Q3 		$2.9M Buy
180,853
+124,793
+223% +$2.26M ﹤0.01% 1594
2024
Q2 		$960K Sell
56,060
-455
-0.8% -$8K ﹤0.01% 1941
2024
Q1 		$883K Buy
56,515
+2,220
+4% +$32.6K ﹤0.01% 2009
2023
Q4 		$811K Buy
+54,295
New +$727K ﹤0.01% 1729
2023
Q3 		– Sell
-6,902
Closed -$286K – 2747
2023
Q2 		$286K Buy
6,902
+1,083
+19% +$67.2K ﹤0.01% 2227
2023
Q1 		$350K Sell
5,819
-1,390
-19% -$111K ﹤0.01% 1812
2022
Q4 		$529K Buy
7,209
+909
+14% +$68.4K ﹤0.01% 1684
2022
Q3 		$478K Buy
6,300
+1,135
+22% +$88.5K ﹤0.01% 1695
2022
Q2 		$360K Buy
5,165
+312
+6% +$23.5K ﹤0.01% 1814
2022
Q1 		$402K Buy
4,853
+851
+21% +$62.7K ﹤0.01% 1909
2021
Q4 		$301K Sell
4,002
-551
-12% -$55.3K ﹤0.01% 2079
2021
Q3 		$528K Sell
4,553
-718
-14% -$109K ﹤0.01% 1863
2021
Q2 		$1.17M Sell
5,271
-3,842
-42% -$747K ﹤0.01% 1453
2021
Q1 		$1.21M Sell
9,113
-94,496
-91% -$14.9M ﹤0.01% 1441
2020
Q4 		$17.9M Buy
103,609
+101,504
+4,822% +$13.9M 0.01% 834
2020
Q3 		$234K Buy
+2,105
New +$168K ﹤0.01% 1625

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Franklin Resources's NVCR Position: Q2 2026 in Review

Franklin Resources increased its NovoCure (NVCR) stake by 50% in Q2 2026, buying an estimated $2.19M and bringing the position to 434,360 shares worth $6.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1470.

Franklin Resources first reported a position in NVCR in Q3 2020 and has held it in 23 quarters since. The position peaked at $17.9M in Q4 2020. 216 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Franklin Resources held 434,360 shares of NovoCure worth $6.58M as of Q2 2026.
  • Franklin Resources bought 145,064 NovoCure shares in Q2 2026, an estimated $2.19M.
  • NovoCure made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1470 holding.
  • Franklin Resources first reported a position in NovoCure in Q3 2020 and has held it in 23 quarters since.
  • Franklin Resources's NovoCure position peaked at $17.9M in Q4 2020.
  • 216 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.